Enteric bacterial flora and bacterial overgrowth syndrome
- PMID: 12462706
Enteric bacterial flora and bacterial overgrowth syndrome
Abstract
Under certain conditions, colonic bacterial flora can colonize the upper small bowel in concentrations sufficient to cause mucosal damage and malabsorption of nutrients, vitamin B12, and fat-soluble vitamins. This situation, known as small bowel bacterial overgrowth syndrome (SBBOS) may be an under-appreciated cause of malnutrition in elderly people. The diagnosis of SBBOS should be considered when patients with known or suspected predisposing conditions have symptoms or findings compatible with this syndrome. However, proof of small bowel bacterial overgrowth requires specialized testing that is not readily available. Moreover, disagreement persists as to how best to test definitively for this disease. Therefore, on a practical level and despite the potential drawbacks of such a decision, SBBOS is usually diagnosed when a compatible syndrome responds to an empirical trial of appropriate oral antibiotics. Improvements on this approach to SBBOS will be built on more widespread access to sensitive, specific, and less cumbersome testing than is currently available.
Similar articles
-
Nutritional consequences of intestinal bacterial overgrowth.Compr Ther. 1994;20(9):523-30. Compr Ther. 1994. PMID: 7805370 Review.
-
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.Aliment Pharmacol Ther. 2005 Jun 1;21(11):1391-5. doi: 10.1111/j.1365-2036.2005.02493.x. Aliment Pharmacol Ther. 2005. PMID: 15932370
-
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.Am J Gastroenterol. 2000 Dec;95(12):3503-6. doi: 10.1111/j.1572-0241.2000.03368.x. Am J Gastroenterol. 2000. PMID: 11151884
-
Diagnosis of small intestinal bacterial overgrowth: the challenges persist!Expert Rev Gastroenterol Hepatol. 2009 Feb;3(1):77-87. doi: 10.1586/17474124.3.1.77. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19210115 Review.
-
Small intestinal bacterial overgrowth in the symptomatic elderly.Am J Gastroenterol. 1997 Jan;92(1):47-51. Am J Gastroenterol. 1997. PMID: 8995936
Cited by
-
Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.Gastroenterol Hepatol (N Y). 2006 Mar;2(3):186-197. Gastroenterol Hepatol (N Y). 2006. PMID: 28286448 Free PMC article.
-
Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.Curr Treat Options Gastroenterol. 2004 Feb;7(1):19-28. doi: 10.1007/s11938-004-0022-4. Curr Treat Options Gastroenterol. 2004. PMID: 14723835
-
Routine disaccharidase testing: are we there yet?Curr Opin Gastroenterol. 2020 Mar;36(2):101-109. doi: 10.1097/MOG.0000000000000614. Curr Opin Gastroenterol. 2020. PMID: 31990709 Free PMC article. Review.
-
Small bowel bacterial overgrowth: presentation, diagnosis, and treatment.Curr Gastroenterol Rep. 2003 Oct;5(5):365-72. doi: 10.1007/s11894-003-0048-0. Curr Gastroenterol Rep. 2003. PMID: 12959716 Review.
-
Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test.J Gastroenterol. 2009;44(9):944-51. doi: 10.1007/s00535-009-0097-8. Epub 2009 Jun 24. J Gastroenterol. 2009. PMID: 19551459 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical